|
Index of reports
> Death (453)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 453 Next >>
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 55.2 kg (121.4 pounds)
Reactions: Unresponsive To Stimuli, Moaning, Neutropenia, Septic Shock, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Start date: 2009-08-21
Methotrexate Sodium
Prednisone
Vincristine
End date: 2012-08-10
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Pain in Extremity, Hypotension, Splenic Infarction, Paraesthesia, Septic Embolus, Fungal Test Positive, Hypoxia, Circulatory Collapse, Asthenia, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, intrathecal
End date: 2012-07-12
Daunorubicin HCL
Dosage: 200 mg
End date: 2012-08-02
Methotrexate
Dosage: 30 m, intrathecal
End date: 2012-08-09
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 4900 iu, intravenous
End date: 2012-07-15
Prednisone
Dosage: 3360 mg, oral
Administration route: Oral
End date: 2012-08-08
Possible Prednisone side effects in male
Reported by a physician from Romania on 2012-08-21
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Cardio-Respiratory Arrest, Anaemia, Dehydration
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-16
End date: 2012-06-16
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-16
End date: 2012-06-16
Possible Prednisone side effects in 68 year old male
Reported by a physician from Canada on 2012-08-21
Patient: 68 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Sudden Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer
Start date: 2012-04-03
End date: 2012-04-03
Prednisone
Indication: Prostate Cancer
Start date: 2012-04-03
Other drugs received by patient: Hydromorphone Hydrochloride; Zometa; Maxeran; Prednisone; Lorazepam
Possible Prednisone side effects in 45 year old female
Reported by a physician from United States on 2012-08-21
Patient: 45 year old female
Reactions: Epstein-Barr Virus Infection, Splenic Infection Fungal, Mycosis Fungoides Refractory, Granuloma, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-06-01
Cisplatin
Dosage: unk
Indication: Mycosis Fungoides
Cyclophosphamide
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Daunorubicin HCL
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Dexamethasone
Dosage: unk
Indication: Mycosis Fungoides
Etoposide
Dosage: unk
Indication: Mycosis Fungoides
Fludara
Dosage: 2 cycles
Indication: Mycosis Fungoides
Ifosfamide
Dosage: unk
Indication: Mycosis Fungoides
Prednisone
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Vincristine
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Possible Prednisone side effects in 77 year old male
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-21
Patient: 77 year old male
Reactions: Adverse Drug Reaction, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Dosage: in cycle 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Dosage: in cycle 1
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: on days 1 to 5
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisone side effects in male
Reported by a consumer/non-health professional from Germany on 2012-08-21
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Cytomegalovirus Infection, Pulmonary Infarction, Lymphoma, Staphylococcal Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-07
End date: 2010-01-11
Doxorubicin HCL
Dosage: 100 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-07
End date: 2010-01-11
Filgrastim
Dosage: 48 unk, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-25
End date: 2010-01-15
Mabcampath
Dosage: 30 mg, day 4 and 5 of each cycle 1-3
Indication: T-Cell Lymphoma
Start date: 2009-12-10
End date: 2010-01-15
Prednisone
Dosage: 10 mg, qd (day 1-5)
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-11-27
End date: 2010-01-10
Vincristine
Dosage: 1 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-11-26
End date: 2010-01-11
Other drugs received by patient: Torsemide; Metoprolol Succinate; Heparin; Marcumar; Pantoprazole; Sulfamethoprim
Possible Prednisone side effects in male
Reported by a physician from Brazil on 2012-08-21
Patient: male, weighing 64.4 kg (141.7 pounds)
Reactions: Diarrhoea
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-11-10
End date: 2012-06-23
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-11-10
End date: 2012-06-23
Other drugs received by patient: Goserelin
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-21
Patient: male, weighing 82.3 kg (181.1 pounds)
Reactions: Oesophageal Squamous Cell Carcinoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 6 milligram
Start date: 2010-10-20
End date: 2010-10-23
Melphalan Hydrochloride
Dosage: 24 milligram
Indication: Multiple Myeloma
Start date: 2009-07-29
Prednisone
Dosage: 195 milligram
Indication: Multiple Myeloma
Start date: 2009-07-29
Prednisone
Dosage: 195 milligram
Start date: 2010-10-20
End date: 2010-10-24
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Start date: 2010-10-20
End date: 2010-10-24
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-07-29
Other drugs received by patient: Prilosec; Acetaminophen; Senna; Zometa; Acetaminophen; Acetaminophen; Aspirin; Antibiotics; Prilosec; Docusate; Procrit; Vitamin B-12; Epoetin Alfa; Acetaminophen; Acetaminophen; Pamidronate Disodium
Possible Prednisone side effects in male
Reported by a physician from Brazil on 2012-08-21
Patient: male, weighing 53.1 kg (116.8 pounds)
Reactions: Pneumonia, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-01
End date: 2012-02-14
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-01
End date: 2012-02-14
Other drugs received by patient: Hydromorphone HCL
Possible Prednisone side effects in 64 year old male
Reported by a physician from Poland on 2012-08-21
Patient: 64 year old male
Reactions: Disseminated Intravascular Coagulation
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Start date: 2012-07-04
End date: 2012-07-04
Cabazitaxel
Indication: Prostate Cancer Metastatic
Start date: 2012-06-14
End date: 2012-06-14
Prednisone
Indication: Prostate Cancer Metastatic
Start date: 2012-06-14
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient: male
Reactions: Central Nervous System Lymphoma, Pyrexia, Thrombocytopenia, Cerebral Toxoplasmosis, Asthenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Istodax
Start date: 2012-03-27
Istodax
Istodax
Start date: 2012-05-30
End date: 2012-05-30
Prednisone
Dosage: 25 milligram
Administration route: Oral
Prednisone
Dosage: 50 milligram
Other drugs received by patient: Levothyroxine Sodium; Prednisone TAB; Omeprazole; Kytril
Possible Prednisone side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 2.5 mg/day
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Possible Prednisone side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 2.5 mg/day
Possible Prednisone side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Prednisone
Dosage: 2.5 mg/day
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Possible Prednisone side effects in male
Reported by a physician from Netherlands on 2012-08-08
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Rectosigmoid Cancer
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Indication: Multiple Myeloma
Start date: 2009-10-13
Melphalan Hydrochloride
Dosage: 15.5 milligram
Administration route: Oral
Start date: 2010-05-25
End date: 2010-05-28
Prednisone
Indication: Multiple Myeloma
Start date: 2009-10-13
Prednisone
Dosage: 170 milligram
Administration route: Oral
Start date: 2010-05-25
End date: 2010-05-28
Thalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-10-13
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Start date: 2010-05-25
End date: 2010-06-21
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient:
Reactions: Hospitalisation, Neuropathy Peripheral, Vomiting, Febrile Neutropenia, Neutropenia, Neutrophil Count Decreased, Lymphoma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: B-Cell Lymphoma
Rituximab
Indication: B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in 27 year old female
Reported by a physician from United States on 2012-08-07
Patient: 27 year old female
Reactions: Drug Resistance, Premature Baby, Transplant Rejection, Hemiparesis, Death, Cerebral Aspergillosis, Liver Transplant Rejection, Chronic Hepatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine Sodium
Indication: Liver Transplant
Cellcept
Dosage: 2000 mg
Indication: Liver Transplant
Prednisone
Dosage: 20 mg
Indication: Liver Transplant
Sirolimus
Indication: Cholestasis
Sirolimus
Indication: Liver Transplant Rejection
Tacrolimus
Indication: Liver Transplant
Possible Prednisone side effects in male
Reported by a physician from Netherlands on 2012-08-06
Patient: male, weighing 84.0 kg (184.8 pounds)
Reactions: Gastric Cancer
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Indication: Multiple Myeloma
Start date: 2009-11-25
End date: 2010-06-30
Prednisone
Indication: Multiple Myeloma
Start date: 2009-11-25
End date: 2010-06-30
Thalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-11-25
End date: 2010-06-30
Possible Prednisone side effects in 74 year old male
Reported by a consumer/non-health professional from United States on 2012-08-03
Patient: 74 year old male
Reactions: Blood Bilirubin Increased, Pneumonia, Atrial Fibrillation, Hepatic Enzyme Increased, Death, Enterococcal Sepsis, Fluid Retention, Cardiac Failure Congestive
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: on days 1,8,15,22
Indication: Acute Lymphocytic Leukaemia
Elspar
Methotrexate
Dosage: day15
Indication: Acute Lymphocytic Leukaemia
Prednisone
Indication: Acute Lymphocytic Leukaemia
Sprycel
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-22
Vincristine
Dosage: on days 1,8,15,22
Indication: Acute Lymphocytic Leukaemia
Possible Prednisone side effects in 76 year old
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 76 year old
Reactions: Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: daily for 5 days
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in
Reported by a physician from Netherlands on 2012-08-02
Patient: , weighing 65.0 kg (143.0 pounds)
Reactions: Renal Cell Carcinoma, Death, NO Therapeutic Response
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Indication: Multiple Myeloma
Start date: 2010-04-23
End date: 2010-08-17
Prednisone
Indication: Multiple Myeloma
Start date: 2010-04-23
End date: 2010-08-17
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-08-24
End date: 2011-04-26
Thalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-23
End date: 2010-08-16
Other drugs received by patient: Dexamethasone
Possible Prednisone side effects in 79 year old male
Reported by a physician from United States on 2012-08-02
Patient: 79 year old male, weighing 75.1 kg (165.2 pounds)
Reactions: Peripheral T-Cell Lymphoma Unspecified
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 5 milligram/sq. meter
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-04-14
Melphalan Hydrochloride
Dosage: 5 milligram/sq. meter
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-05
Prednisone
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-14
Prednisone
Dosage: 100 milligram
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-05
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-04-14
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-22
Other drugs received by patient: Aspirin; Zometa
Possible Prednisone side effects in 85 year old
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 85 year old
Reactions: Cardiomyopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Cyclophosphamide
Dosage: reduced dose
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: reduced dose
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Prednisone
Dosage: reduced dose
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: daily for 5 days
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Dosage: reduced dose
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: reduced dose
Other drugs received by patient: Neupogen
Possible Prednisone side effects in 74 year old male
Reported by a physician from Mexico on 2012-08-01
Patient: 74 year old male, weighing 65.0 kg (143.0 pounds)
Reactions: Pulmonary Oedema, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer
Start date: 2012-04-04
End date: 2012-04-04
Prednisone
Administration route: Oral
Indication: Prostate Cancer
Start date: 2012-04-04
Possible Prednisone side effects in male
Reported by a physician from United Kingdom on 2012-08-01
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Alveolitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Docetaxel
Dosage: 144 milligram
Indication: Prostate Cancer
Start date: 2010-09-17
Docetaxel
Dosage: 144 milligram
Start date: 2010-10-08
End date: 2010-10-08
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Start date: 2010-10-08
End date: 2010-10-21
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-09-17
Prednisone
Dosage: 10 milligram
Indication: Prostate Cancer
Start date: 2010-09-17
Prednisone
Dosage: 10 milligram
Start date: 2010-10-08
End date: 2010-10-08
Other drugs received by patient: Frusemide; Clarithromycin; Omeprazole; Acetaminophen and Codeine Phosphate; Dexamethasone; Clarithromycin; Enoxaparin; Ondansetron
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-31
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Prednisone side effects in
Reported by a physician from Netherlands on 2012-07-30
Patient: , weighing 65.0 kg (143.0 pounds)
Reactions: Renal Cell Carcinoma, Death, NO Therapeutic Response
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Indication: Multiple Myeloma
Start date: 2010-04-23
End date: 2010-08-17
Prednisone
Indication: Multiple Myeloma
Start date: 2010-04-23
End date: 2010-08-17
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-08-24
End date: 2011-04-26
Thalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-23
End date: 2010-08-16
Other drugs received by patient: Dexamethasone
Possible Prednisone side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 46 year old female
Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carmustine
Cyclophosphamide
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Cytarabine
Dosage: 1.5 g/d/m2 (1 cycle)
Doxorubicin Hydrochloride
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Idarubicin HCL
Dosage: 12 mg/d/m2 (1 cycle)
Melphalan Hydrochloride
Oncovin
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Vorinostat
Dosage: 1 cycle
Administration route: Oral
Possible Prednisone side effects in male
Reported by a physician from France on 2012-07-30
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Lung Disorder, Bone Marrow Failure, Coma, Intracranial Pressure Increased, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carmustine
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-06-02
End date: 2012-06-02
Cytarabine Hydrochloride and Cisplatin and Dexamethasone and Etoposide
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-06-01
End date: 2012-06-01
Mabthera
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-31
End date: 2012-05-31
Methotrexate
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-31
End date: 2012-05-31
Prednisone
Dosage: cumulative dose 575 mg, last dose received on 04/jun/2012 was 115 mg
Administration route: Oral
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-31
End date: 2012-06-04
Other drugs received by patient: Methylprednisolone
Page 1 Next >>
|
